Dourdan, France

Jean-Michel Arrang

USPTO Granted Patents = 13 

Average Co-Inventor Count = 8.1

ph-index = 7

Forward Citations = 122(Granted Patents)


Location History:

  • Gif, FR (1988)
  • Gif /Yvette, FR (1987 - 1994)
  • Gif Sur Yvette, FR (1991 - 2001)
  • Dourdon, FR (2011)
  • Dourdan, FR (2006 - 2012)
  • Dourdan, ES (2013)

Company Filing History:


Years Active: 1987-2013

Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Jean-Michel Arrang: Innovator in Sleep Apnea Treatment**

Introduction

Jean-Michel Arrang is an accomplished inventor based in Dourdan, France, recognized for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 13 patents, Arrang has made strides in the field of medicinal chemistry, particularly in treatments related to sleep apnea. His unique inventions focus on improving the efficacy of therapeutic compounds.

Latest Patents

Among his notable inventions is the crystalline monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine. This compound provides a method for treating sleep apnea and other related conditions. The innovation details an effective administration of a crystalline form of the compound, which has a specific X-ray diffractogram characterized by peaks at 11.2°, 19.9°, 20.7°, and 34.1° ± 0.2°.

Another patent from Arrang includes the new crystalline form of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, along with its manufacturing processes and potential uses in medical compositions. These innovative formulations are key in addressing various ailments, particularly sleep-related disorders.

Career Highlights

Throughout his career, Jean-Michel Arrang has worked with renowned organizations, such as Société Civile Bioprojet and the Institut National De La Santé et de la Recherche Médicale (INSERM). His collaborations in these esteemed institutions highlight his commitment to research and development in medical therapeutics.

Collaborations

Arrang has partnered with prominent colleagues, including Jean-Charles Schwartz and Monique Garbarg. These collaborations have been instrumental in advancing the collective knowledge and capabilities in the field of pharmaceutical innovations.

Conclusion

Jean-Michel Arrang's contributions to medicinal chemistry, particularly in the treatment of sleep apnea, underscore his role as a significant inventor. With his innovative patents and collaborative efforts, he continues to make impactful advancements that can greatly enhance patient care and treatment options in the medical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…